Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apple Inc. stock logo
AAPL
Apple
$189.87
+0.0%
$174.13
$164.07
$199.62
$2.91T1.2664.99 million shs41.28 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$154.64
+0.2%
$152.31
$143.13
$175.97
$372.17B0.557.88 million shs6.52 million shs
Microsoft Co. stock logo
MSFT
Microsoft
$420.21
-0.2%
$415.05
$309.45
$430.82
$3.12T0.8920.31 million shs15.35 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.64
-1.0%
$27.20
$25.20
$40.37
$162.29B0.6345.22 million shs26.11 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apple Inc. stock logo
AAPL
Apple
0.00%+3.73%+13.67%+4.15%+9.95%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.03%+3.16%+6.11%-1.22%-2.74%
Microsoft Co. stock logo
MSFT
Microsoft
0.00%+1.32%+3.94%+4.00%+33.82%
Pfizer Inc. stock logo
PFE
Pfizer
-0.02%+2.25%+12.82%+3.69%-22.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apple Inc. stock logo
AAPL
Apple
4.8115 of 5 stars
2.35.03.32.82.52.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8608 of 5 stars
3.23.04.23.92.61.71.9
Microsoft Co. stock logo
MSFT
Microsoft
4.8542 of 5 stars
2.55.03.32.92.52.52.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9967 of 5 stars
4.25.04.24.82.51.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apple Inc. stock logo
AAPL
Apple
2.62
Moderate Buy$204.717.81% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8613.72% Upside
Microsoft Co. stock logo
MSFT
Microsoft
2.94
Moderate Buy$454.708.21% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.40
Hold$35.8625.20% Upside

Current Analyst Ratings

Latest AAPL, JNJ, MSFT, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
Microsoft Co. stock logo
MSFT
Microsoft
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$460.00 ➝ $475.00
5/17/2024
Microsoft Co. stock logo
MSFT
Microsoft
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$450.00 ➝ $500.00
5/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00
5/13/2024
Apple Inc. stock logo
AAPL
Apple
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$250.00
5/6/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
5/4/2024
Apple Inc. stock logo
AAPL
Apple
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$200.00 ➝ $215.00
5/3/2024
Apple Inc. stock logo
AAPL
Apple
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$200.00 ➝ $215.00
5/3/2024
Apple Inc. stock logo
AAPL
Apple
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$225.00 ➝ $230.00
5/3/2024
Apple Inc. stock logo
AAPL
Apple
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$210.00 ➝ $216.00
5/3/2024
Apple Inc. stock logo
AAPL
Apple
Itau BBA Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Market Perform$162.00 ➝ $188.00
5/3/2024
Apple Inc. stock logo
AAPL
Apple
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$250.00
(Data available from 5/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apple Inc. stock logo
AAPL
Apple
$383.29B7.60$6.98 per share27.21$4.84 per share39.23
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.37$13.66 per share11.32$29.09 per share5.32
Microsoft Co. stock logo
MSFT
Microsoft
$211.92B14.74$11.73 per share35.82$34.06 per share12.34
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.77$2.98 per share9.62$16.33 per share1.75

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apple Inc. stock logo
AAPL
Apple
$97.00B$6.4329.5326.372.2826.31%148.33%29.13%8/1/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.6414.162.5545.26%36.70%15.07%7/18/2024 (Estimated)
Microsoft Co. stock logo
MSFT
Microsoft
$72.36B$11.5536.3831.882.2236.43%37.54%19.02%7/23/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.381.21-0.56%8.64%3.70%8/6/2024 (Estimated)

Latest AAPL, JNJ, MSFT, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q2 2024
Apple Inc. stock logo
AAPL
Apple
$1.51$1.53+$0.02$1.53$90.37 billion$90.75 billion    
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
4/25/2024Q3 2024
Microsoft Co. stock logo
MSFT
Microsoft
$2.81$2.94+$0.13$2.94$60.86 billion$61.86 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apple Inc. stock logo
AAPL
Apple
$1.000.53%+5.57%15.55%13 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.08%+5.70%29.68%63 Years
Microsoft Co. stock logo
MSFT
Microsoft
$3.000.71%+10.11%25.97%22 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.685.87%+2.57%N/A 15 Years

Latest AAPL, JNJ, MSFT, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
3/12/2024
Microsoft Co. stock logo
MSFT
Microsoft
quarterly$0.750.72%5/15/20245/16/20246/13/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
5/2/2024
Apple Inc. stock logo
AAPL
Apple
quarterly$0.250.58%5/10/20245/13/20245/16/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apple Inc. stock logo
AAPL
Apple
1.24
1.04
0.99
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.94
Microsoft Co. stock logo
MSFT
Microsoft
0.17
1.24
1.23
Pfizer Inc. stock logo
PFE
Pfizer
0.66
1.05
0.78

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apple Inc. stock logo
AAPL
Apple
60.41%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Microsoft Co. stock logo
MSFT
Microsoft
71.13%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Apple Inc. stock logo
AAPL
Apple
0.06%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Microsoft Co. stock logo
MSFT
Microsoft
0.03%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apple Inc. stock logo
AAPL
Apple
161,00015.33 billion15.32 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
Microsoft Co. stock logo
MSFT
Microsoft
221,0007.43 billion7.43 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable

AAPL, JNJ, MSFT, and PFE Headlines

Recent News About These Companies

Pfizer (NYSE:PFE) Trading Down 1.3%
Pfizer (NYSE:PFE) Stock Price Down 1.3%
Pfizer Stock: Rebound Has Started (Technical Analysis)
7 Value Stocks to Buy and Hold for a Decade of Dominance
Pfizer (NYSE:PFE) Shares Down 0.1%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Apple logo

Apple

NASDAQ:AAPL
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts. In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Microsoft logo

Microsoft

NASDAQ:MSFT
Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.